Back to Search
ANDY NORMAN, MD
MD
Obstetrics & Gynecology Physician
NPI: 1689634032Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MD25257(TN)
Research & Publications (20)
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
PMID 19672261·Br J Cancer·2009
8-other
Conjugative plasmids: vessels of the communal gene pool.
PMID 19571247·Philos Trans R Soc Lond B Biol Sci·2009
6-review
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
PMID 19474114·Ann Oncol·2009
1-meta
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
PMID 19398575·J Clin Oncol·2009
4-observational
The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling.
PMID 19531804·Sci Signal·2009
6-review
Prospective study of factors predicting adherence to medical advice in men with testicular cancer.
PMID 19307514·J Clin Oncol·2009
8-other
Prenatally induced changes in muscle structure and metabolic function facilitate exercise-induced obesity prevention.
PMID 19477938·Endocrinology·2009
7-preclinical
The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer.
PMID 19188240·Br J Radiol·2009
8-other
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
PMID 19164454·Ann Oncol·2009
4-observational
Long-term behavioral consequences of prenatal MDMA exposure.
PMID 19162054·Physiol Behav·2009
4-observational
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.
PMID 19104814·Cancer Chemother Pharmacol·2009
3-trial
sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.
PMID 19324528·Int J Antimicrob Agents·2009
8-other
The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats.
PMID 19088302·J Pharmacol Exp Ther·2009
7-preclinical
Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells.
PMID 19074549·Mol Endocrinol·2009
7-preclinical
Treating IIA/B seminoma with combination carboplatin and radiotherapy.
PMID 19289608·J Clin Oncol·2009
8-other
Uptake and biotransformation of structurally diverse brominated flame retardants in zebrafish (Danio rerio) after dietary exposure.
PMID 19049262·Environ Toxicol Chem·2009
7-preclinical
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
PMID 19040532·BJU Int·2009
8-other
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
PMID 18762814·Prostate Cancer Prostatic Dis·2009
8-other
Pilot study utilizing a patient educational brochure at a vesicovaginal fistula hospital in Nigeria, Africa.
PMID 18810301·Int Urogynecol J Pelvic Floor Dysfunct·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 THE VANDERBILT CLINIC
NASHVILLE, TN 37232 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1689634032
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile